Aims Inflammation, endothelial cell function and the coagulation system have been demonstrated to be involved in the onset and course of unstable angina. Whether a proinflammatory state independently determines outcome is unknown and has not been determined yet in a clinically well defined study population of consecutive patients admitted with unstable angina.
Introduction
It is generally accepted that acute coronary syndromes are the result of abrupt changes in the atherosclerotic plaque that lead to local thrombus formation [1, 2] . In unstable angina, refractoriness to medical therapy may be the result of persistent plaque instability, and carries a high risk for the occurrence of myocardial infarction and cardiac death [3] . The underlying pathogenetic mechanisms leading to persistent instability and refractoriness to medical therapy have not been fully elucidated. There is evidence that inflammatory and thrombotic processes, interacting with the endothelial cells, are important determinants of the clinical course of patients with unstable angina. Several studies reported that systemic or local infections are associated with the occurrence of acute coronary syndromes [4] [5] [6] . Histopathological studies have indicated that activation and accumulation of white blood cells in the atherosclerotic plaque are associated with increased risk of acute coronary syndromes [7] [8] [9] [10] [11] [12] [13] [14] . Activation of the coagulation process has been demonstrated to be involved in the onset and course of unstable angina [15] [16] [17] . The findings that monocytes induce hypercoagulability in patients with unstable angina [18] and the central role of the acute phase protein fibrinogen in coagulation [19] , suggest a relationship between inflammation and coagulation.
In patients with stable or unstable angina, the association between various biochemical markers and outcome has been analysed [15] [16] [17] [18] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . However, with regard to unstable angina, data about inflammatory, haemostatic and endothelial markers, simultaneously determined in a clinically well defined unselected population, are lacking. Therefore we determined the correlation between inflammatory markers and subsequent clinical course, as well as the contribution of haemostatic factors and markers of endothelial cell function in 211 patients with unstable angina.
Methods

Patients
Selection took place on admission to hospital and was based on patient history and the initial standard 12-lead electrocardiogram. Inclusion criteria were: Typical angina at rest within 24 h before admission lasting less than 30 min in combination with either: (1) myocardial ischaemia as reflected in ST-segment depression exceeding 0·1 mV, ST-segment elevation not exceeding 0·1 mV, or T-wave inversion, or: (2) electrocardiographic evidence of coronary artery disease based on prior Q wave myocardial infarction or: (3) previous coronary angiography showing at least 50% lumen diameter narrowing in at least one large epicardial coronary artery. Exclusion criteria were: (1) invalid ST-segment diagnosis caused by atrial fibrillation, left bundle branch block, left ventricular hypertrophy or pacemaker rhythm, without a history of proven coronary artery disease: (2) intercurrent inflammatory or neoplastic disease likely to be associated with acute phase responses: (3) lack of informed consent.
All patients received standard medical therapy unless contraindicated, i.e. aspirin 300 mg orally, nitroglycerine intravenously and a heparin infusion guided by the activated partial thromboplastin time. Beta-receptor blocking agents and/or diltiazem were added at the discretion of the treating physician. All decisions regarding the care of patients were made solely on the basis of good clinical practice.
Myocardial infarction during admission (inhospital myocardial infarction) was defined as typical chest pain during hospital stay with a concomitant rise in creatine kinase levels of more than twice normal values. Patients with a (non-Q wave) myocardial infarction not recognised on admission because of insufficient electrocardiographic criteria, and who had biochemical evidence of myocardial necrosis within 12 h from admission, were scored to have an out-of-hospital (non-Q wave) infarction.
The study protocol was approved by the Ethics Committee of the Leiden University Medical Centre.
End-point
The end-point of the study was the occurrence of refractory unstable angina. Unstable angina was considered to be refractory if, in spite of optimal medical therapy, angina at rest reoccurred and led to the decision to perform urgent coronary angiography to determine the possibilities for PTCA or bypass surgery. The decision to perform urgent coronary angiography was taken by the attending physician who was unaware of the outcome of the assays below. A fully equipped catheterization laboratory was available 24 h a day.
Blood collection
Venous blood samples were collected on admission prior to the start of medication. Blood was collected into CTAD tubes (=0·11 mol . 
Assays
Markers of inflammation C-reactive protein was measured in serum by a nephelometric method, range 0·2 to 1100 mg . l 1 (N Latex CRP mono, Behring Diagnostics). Fibrinogen was determined according to the method of von Clauss [32] using, as a standard, pooled citrated plasma (n=25) in which the fibrinogen level was determined by a gravimetric method [33] . Erythrocyte sedimentation rate was measured by the modified Westergren method.
Markers of activation of coagulation and endothelial function
Prothrombin fragments 1+2 and thrombinantithrombin complex levels were determined with enzyme immunoassays (Behringwerke, Marburg, Germany). Tissue type plasminogen activator levels were determined with an enzyme immunoassay (Imulyse t-PA, Biopool AB, Sweden). Plasminogen activator inhibitor activity levels were determined using the CTAD plasma with the method described by Verheijen et al. [34] . Von Willebrand Factor was 
Coronary angiography
Selective coronary angiography was performed in multiple views using the Judkins technique, in accordance with the current practice at our institution. Patients with refractory unstable angina underwent diagnostic catheterization on an emergency basis. A narrowing of >50% in the diameter of the coronary arteries was considered significant coronary stenosis. Patients were classified as having 1-, 2-, or 3-vessel or bypass graft disease according to the (number of) vessels with significant stenosis.
Statistical analysis
Characteristics of patients with refractory unstable angina and patients who could be stabilized were compared using the unpaired Student's t-test, MannWhitney test or Pearson chi-square test where appropriate. All markers, except the von Willebrand Factor and cellular fibronectin, were log transformed because of their skewed distributions. Consequently the geometric instead of the arithmetric means are reported for these variables. The risk of refractory unstable angina was related to patient characteristics using the logistic regression model. Odds ratio estimates were adjusted for age, sex, body mass index, smoking behaviour and cholesterol level.
Results
Patient inclusion
During the inclusion period of 18 months, a total of 294 patients referred from home were admitted with the initial diagnosis unstable angina. Of these, 48 were excluded: 30 had invalid ST-segment diagnosis, 15 had intercurrent inflammatory or neoplastic disease and in three informed consent was lacking. Of the remaining 246 patients, 35 were not enrolled for procedural reasons. We thus included 211 patients. Of these, 150 (71%) were men. Mean age was 63 years, ranging from 33 to 85 years.
Baseline patient characteristics and in-hospital outcome
Baseline clinical characteristics of all patients are summarized in Tables 1 and 2, according to clinical outcome. The majority of these variables were comparable between stabilized and refractory patients. A history of intermittent claudication, the use of longacting nitrates, levels of glucose on admission and the sum of ST-segment depressions in the 12-lead admission electrocardiogram differed significantly by univariate analysis between the two patient groups according to outcome.
Clinical outcome
Hospital stay varied from 1 to 26 days, with a mean of 4·7 days. The clinical end-point refractory unstable angina prompting urgent coronary angiography to guide further therapy, was observed in 76 patients (36%). Of these, six died of cardiac causes, 10 developed an acute in-hospital myocardial infarction and 63 were subjected to emergency PTCA or CABG. The remaining 135 patients (64%) became symptom-free with medical therapy only. No in-hospital myocardial infarction, cardiac death or urgent revascularization procedure was observed in this group. A retrospectively diagnosed out-of-hospital (non-Q wave) infarction had occurred in 21 patients: 10 (13%) of these experienced refractory unstable angina, and 11 (8%) patients could be stabilized (P=0·3). Plasma troponin-T levels on admission were elevated (>0·20 ng . ml 1 ) in 20 patients. Of these, 12 experienced refractory unstable angina and eight could be stabilized (16% vs 6%, P<0·05).
Coronary angiography
In the group of patients who could be stabilized, 71 underwent coronary angiography during hospital stay. Of these, 10 patients showed no significant stenosis, 21 had one-vessel disease, 13 two-vessel disease, nine threevessel disease, one patient had left main disease and 17 had bypass graft disease. In two patients in the group with refractory unstable angina, angiography was not performed because this had recently been done. Of the remaining 74 patients, three showed no significant stenosis, 24 had one-vessel disease, 15 two-vessel disease, 16 three-vessel disease, five left main disease and 11 bypass graft disease.
Inflammatory markers and in-hospital outcome
On admission, the mean levels of the inflammatory markers C-reactive protein, fibrinogen and erythrocyte sedimentation rate, were significantly higher in patients in whom refractory unstable angina occurred during admission, when compared with those who could be stabilized: geometric means (coefficient of variation) for C-reactive protein were 3·36 (1·11) mg . (Table 3) . In a multivariate analysis using logistic regression after adjustment for age, sex, body mass index, smoking behaviour and cholesterol levels, the odds ratios (95% CI) for the risk of having refractory unstable angina according to the highest quartile compared to the lowest quartile of levels of inflammatory markers, were 2·19 (0·94-5·11) for C-reactive protein, 2·83 (1·13-7·10) for fibrinogen and 4·72 (1·70-13·09) for the erythrocyte sedimentation rate (Table 4 and Fig. 1 ). Fibrinogen and the erythrocyte sedimentation rate correlated significantly (correlation coefficient r=0·57, P<0·001). The association between fibrinogen and outcome weakened considerably when corrected for the erythrocyte sedimentation rate: the odds ratio became 1·32 (0·45-368). When corrected for fibrinogen, the odds ratio for ESR measured 2·92 (0·91-9·30).
Inflammatory markers in relation to myocardial necrosis
On admission, 20 patients had elevated levels of troponin-T (>0·20 ng . ml 1 ), a sensitive and specific maker for myocardial necrosis [35] . To rule out the influence of myocardial necrosis on the acute phase reactants [36] [37] [38] [39] , we separately studied the association between the inflammatory markers and in-hospital outcome in the group of patients in whom troponin-T levels were not increased. Also in this group of 191 patients, significantly higher levels of C-reactive protein, fibrinogen and erythrocyte sedimentation rate were observed in patients with refractory unstable angina as compared with patients who could be stabilized with medical therapy only: geometric means (coefficient of variation) for C-reactive protein were 3·30 (1·06) mg . l 1 
Haemostatic markers and markers of endothelial cell function and in-hospital outcome
No relationship was observed between in-hospital outcome and either levels of the endothelial function 
Values are odds ratios with 95% confidence intervals. *Adjusted for age, sex, body mass index, smoking and baseline levels of total cholesterol. †ESR=erythrocyte sedimentation rate.
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markers (von Willebrand factor and cellular fibronectin), the fibrinolytic key components (tissue type plasminogen activator and plasminogen activator inhibitor activity) or markers of activation of the coagulation system (thrombin-antithrombin complex and prothrombin fragments 1+2) ( Table 4 ). These findings remained essentially unchanged after adjustment for age and sex. As coumarin use may have affected levels of haemostatic markers, especially thrombin-antithrombin complex and prothrombin fragments 1+2, subgroup analysis was performed in the 158 patients who were not on coumarin when admitted. The association between levels of the inflammatory markers and outcome did not importantly change, while again no correlation could be demonstrated between the haemostatic makers and in-hospital course.
Discussion
In this prospective study on inflammatory activity, markers of haemostasis and of endothelial cell function in consecutive patients with unstable angina pectoris, levels of C-reactive protein, fibrinogen and erythrocyte sedimentation rate on admission were associated with in-hospital outcome. Mean levels of the markers did not differ with respect to the duration of symptoms before admission. No association was found between markers of coagulation activation or endothelial cell function on the one hand, and in-hospital course on the other. These findings suggest that increased inflammatory activity reflects the severity of the underlying process and determines the clinical course. To our knowledge this is the first study in which inflammatory markers were compared to haemostatic and endothelial function markers in a consecutive group of patients with severe unstable angina.
The present findings support the concept that inflammation is a key mechanism in unstable angina [12] [13] [14] [15] . A low-grade chronic inflammatory response is central in the most cohesive theory of atherogenesis, the 'response to injury' hypothesis [40] . Accepted features of the atherosclerotic lesion include infiltrates of smooth muscle cells as well as monocytes, macrophages and lymphocytes, characteristic of chronic inflammation. These cells are important regulators of plaque stability and the release of inflammatory markers probably reflects the biological activity in the coronary plaque. Thus, alterations in coronary plaque morphology and function might be revealed by increased levels of inflammatory markers. An important issue when interpreting measured inflammatory activity and severity of disease as reflected by clinical course, is the possible causal relationship between inflammation and atherosclerotic heart disease. The inflammatory markers fibrinogen and C-reactive protein may only serve as a reflection of the underlying biological processes triggered by plaque rupture. However, a causal role cannot be excluded as they also may reflect a pro-inflammatory state, with possibly negative effects on healing processes in the unstable plaque. The lack of difference that we observed in levels of inflammatory markers in patients with a short interval, compared with those with a long interval between onset of unstable angina and blood collection, in combination with the findings mentioned above, supports the concept that a proinflammatory state may already exist before onset of plaque instability, and that the increased inflammatory activity is not merely a reflection of the acute intracoronary process. Many yet undetermined toxic, infectious or immunological factors may be responsible for the inflammatory process by the stimulation of the production of proinflammatory mediators leading to the acute phase response with heightened levels of C-reactive protein and fibrinogen. When a plaque ruptures, this proinflammatory milieu may enhance the processes leading to persistent instability. Yet largely unknown triggers activate the endothelium to release interleukin-6, which in turn stimulates the liver to produce C-reactive protein [22] . There is some evidence that C-reactive protein not only serves as a marker of the acute phase response, but is also involved in the pathogenesis of the disease. C-reactive protein stimulates the production of tissue factor [41] , the main initiator of blood coagulation, by mononuclear cells. C-reactive protein interacts with lowdensity lipoproteins [42] and can also activate the complement system [43] . These properties may contribute to instability of the plaque and the subsequent clinical course.
Fibrinogen is a major determinant in the generation of fibrin-platelet plugs and thrombus formation, suggesting a causative association with coronary thrombosis [19] . The mechanism by which fibrinogen influences the onset and course of atherosclerotic heart disease is not fully understood. Our findings that fibrinogen -but not the other haemostatic markers -is associated with prognosis suggest that fibrinogen is involved in the Epidemiological studies have demonstrated a significant association between elevated erythrocyte sedimentation rate and the risk of coronary heart disease in apparently healthy men [25, 26] . The erythrocyte sedimentation rate mainly reflects a mutual relationship between plasma proteins. Fibrinogen accelerates erythrocyte sedimentation rate by enhancing the erythrocyte agglutination process. A correlation between fibrinogen and erythrocyte sedimentation rate was observed, and after correction for the erythrocyte sedimentation rate, the association between fibrinogen and outcome strongly weakened, suggesting that plasma components other than fibrinogen may be involved in the clinical course of unstable angina. Further studies may contribute to explain this intriguing finding. Correction for haemoglobin levels, a factor that may influence the erythrocyte sedimentation rate, did not importantly affect the results.
Myocardial necrosis could be the trigger for an acute phase response in patients with unstable angina [36] [37] [38] . To exclude a possible contribution of myocardial necrosis on the inflammatory markers, we also determined the relationship between inflammatory markers and outcome in a subgroup of patients with normal troponin-T levels (<0·20 ng . ml 1 ) and in a subgroup of patients in whom out-of-hospital (non-Q wave) infarction was ruled out. The association between inflammatory markers and in-hospital prognosis persisted in both subgroups. This observation indicates that the activation of inflammation in unstable angina is not exclusively caused by myocardial necrosis.
No association could be demonstrated between levels of markers of coagulation activation thrombinantithrombin complex, prothrombin fragments 1+2, the fibrinolytic key components tissue type plasminogen activator, plasminogen activator inhibitor, and markers of endothelial cell function von Willebrand Factor and cellular fibronectin, and the in-hospital course. Von Willebrand factor significantly correlated with all three inflammatory markers, whereas the other haemostatic and endothelial markers did not, supporting a role for von Willebrand Factor in the acute phase response. Levels of markers of coagulation thrombinantithrombin complex and prothrombin fragments 1+2 may have been influenced by the use of coumarin therapy. Subanalysis of patients who were not on coumarin revealed no important changes in the results. As a consequence of the study protocol we were not able to account for the influence of the circadian variation of thrombin-antithrombin complex and plasminogen activator inhibitor levels in relation to in-hospital outcome. Activation of coagulation and impaired fibrinolysis have been associated with an unfavourable course in patients with unstable angina in certain earlier studies. The results of these studies are not entirely in concordance, which in part may be due to differences in patient inclusion criteria, study end-points or measurement techniques of the various thrombotic markers. We wish to stress that our findings do not negate the concept of thrombus formation and endothelial dysfunction as important determinants of the pathogenesis of unstable angina. However, in our study population measurements of circulating markers of haemostasis and endothelial function were not informative in qualifying the severity of the disease as indicated by the clinical course.
We conclude that in this clinically representative and well-defined study population of patients with unstable angina, levels of inflammatory markers on admission correlate well with short-term outcome. The findings were independent of established cardiovascular risk factors and could neither be related to myocardial necrosis, thrombotic and fibrinolytic state or endothelial cell function. Our findings support the hypothesis that heightened inflammatory activity is a key mechanism in the pathophysiology of unstable angina and determines the clinical course.
